• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Why Some COVID-19 Testing Protocols Aren’t What You Think

by Pawel Czech, the founder of Nex.D & GeneMe 12/18/2020 Leave a Comment

Some COVID-19 Testing Protocols Aren’t What You Think

Pawel Czech, Founder of Nex.D While countries around the world continue to flounder with regards to COVID-19 testing, everyone is wondering how national governments could get things so horribly wrong. It’s true that governments have acted incompetently, leaders can make poor judgment calls, and optimistic testing targets are rarely achieved. But the claims of various ambitious big pharma companies—about their ability to deliver on capacity and accuracy alike—have created a smokescreen for
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Digital Diabetes Market to Reach $1.5B by 2024, Research Finds

by Jasmine Pennic 12/14/2020 Leave a Comment

Diabetes Management Apps Global Mobile Health Solutions_7 Best Practices for Developing Successful Diabetes Mobile Apps

What You Should Know: - The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.  - Digital diabetes solutions have disrupted the
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

White House Coronavrius Task Force Doubles Down on Rapid Testing Strategy

by Liz Essley Whyte, Reporter, Center for Public Integrity 11/16/2020 Leave a Comment

White House, IBM Partner to Fight COVID-19 Using Supercomputers

What You Should Know: - White house coronavirus task force doubles down on rapid testing strategy to fight the coronavirus as some states say they don’t have the supplies to comply with the federal government’s advice. - This article was originally published by the Center for Public Integrity, a nonprofit investigative news organization based in Washington, D.C. The White House coronavirus task force is doubling down on part of its strategy for halting the spread of the virus:
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients

by Julie Tyler, Divisional Vice President of Global Marketing, Abbott’s Vascular Division 11/04/2020 Leave a Comment

How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients

Abbott recently released global research on vascular patient care, designed to shine a light on the vascular patient journey. The report called “Beyond Intervention” uncovers the universal challenges faced by physicians who deliver vascular care, their patients, and the hospital administrators who support them. It also explores how the right use of technology and data could potentially enable more precise diagnoses and better treatment strategies to ensure the best possible patient
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe

by Fred Pennic 09/28/2020 Leave a Comment

Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe

What You Should Know: - Abbott has received CE Mark (European approval) for its next-generation FreeStyle Libre 3 system for people with diabetes. - FreeStyle Libre 3 is the latest advancement from Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies) and a more environmentally sustainable system design. Abbott, the worldwide leader in continuous glucose
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

COVID-19 Infects Patient & Practitioner Demands, Unsettling the Future of Hospital Operations

by Eric Stone, CEO at Velano Vascular 07/16/2020 Leave a Comment

COVID-19 Infects Patient & Practitioner Demands, Unsettling the Future of Hospital Operations

Eric Stone, Co-Founder & CEO at Velano Vascular Prior to the outbreak of COVID-19, the healthcare industry in the United States was in the midst of an intense refocusing on patient-centered care. This evolution was defined by a number of innovations, policies, and even federal reimbursement programs that prioritized emphasis on and impact on the patient experience. It led to changes in everything from the quality of hospital food, valet parking, and room amenities to fundamentally
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

2020 Fortune/IBM Watson Health 100 Top Hospitals List

by Jasmine Pennic 07/01/2020 Leave a Comment

2020 Fortune/IBM Watson Health 100 Top Hospitals List

What You Should Know: - Fortune and IBM Watson Health named the 100 Top Hospitals that are setting new standards for using technology to improve operational efficiency, quality care and safety. - The rapid shift to virtual care amid COVID-19 put a bigger spotlight on the barriers impeding digital transformation, but this year’s top hospitals are leading the way for practical approaches to using telehealth and predictive modeling as well as data as a foundational measure to align
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

In-Depth: 32 FDA-Approved COVID-19 Testing Kits

by Kayla Matthews 04/23/2020 Leave a Comment

FDA Approves COVID-19 Oral Fluid Test for Use Nationwide

What You Should Know: - In-depth look list of FDA-approved COVID-19 test kits The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.  The FDA makes a
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Omada Health Integrates With Abbot’s Freestyle Libre for People with Type 2 Diabetes

by Jasmine Pennic 10/14/2019 Leave a Comment

Omada Health Integrates With Abbot’s Freestyle Libre for People with Type 2 Diabetes

- Collaboration combines Abbott′s world-leading glucose sensing technology with Omada Health's best-in-class, proprietary digital coaching platform to provide personalized, on-the-go care.- As part of Omada’s expanded Type 2 diabetes offering, FreeStyle Libre will be the exclusive CGM delivered directly to participants’ doorsteps – expanding access to the technology for more people with diabetes.Abbott and Omada Health announced they are partnering to integrate Abbott's revolutionary FreeStyle
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data

by Jasmine Pennic 09/16/2019 Leave a Comment

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data

- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |